Generation and immunosuppressive functions of p53-induced human adaptive regulatory T cells

Por Mandapathil, Magis, Visus, Carmen, Finn, Olivera J, Lang, Stephan, Whiteside, Theresa L
Publicado em 2013

SPONTANEOUS APOPTOSIS OF TUMOR-SPECIFIC TETRAMER(+) CD8(+) T LYMPHOCYTES IN THE PERIPHERAL CIRCULATION OF PATIENTS WITH HEAD AND NECK CANCER

Por Albers, Andreas E., Schaefer, Carsten, Visus, Carmen, Gooding, William, DeLeo, Albert B., Whiteside, Theresa L.
Publicado em 2009

Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8(+) T Lymphocytes()

Por Wieckowski, Eva U., Visus, Carmen, Szajnik, Marta, Szczepanski, Miroslaw J., Storkus, Walter J., Whiteside, Theresa L.
Publicado em 2009

Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696)

Por Schaefer, Carsten, Butterfield, Lisa H., Lee, Sandra, Kim, Grace G., Visus, Carmen, Albers, Andreas, Kirkwood, John M., Whiteside, Theresa L.
Publicado em 2012

Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8(+) T-cell-defined human tumor antigen of human carcinomas

Por Visus, Carmen, Ito, Diasuke, Dhir, Rajiv, Szczepanski, Miroslaw J., Chang, Yoo Jung, Latimer, Jean J., Grant, Stephen G., DeLeo, Albert B.
Publicado em 2011

17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

Por Szajnik, Marta, Szczepanski, Miroslaw J., Elishaev, Esther, Visus, Carmen, Lenzner, Diana, Zabel, Maciej, Glura, Marta, DeLeo, Albert B., Whiteside, Theresa L.
Publicado em 2012

Phase I dendritic cell p53 peptide vaccine for head and neck cancer

Por Schuler, Patrick J., Harasymczuk, Malgorzata, Visus, Carmen, DeLeo, Albert, Trivedi, Sumita, Lei, Yu, Argiris, Athanassios, Gooding, William, Butterfield, Lisa H., Whiteside, Theresa L., Ferris, Robert L.
Publicado em 2014

Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide

Por Hendrickson, Ronald C., Cicinnati, Vito R., Albers, Andreas, Dworacki, Grzegorz, Gambotto, Andrea, Pagliano, Ornella, Tüting, Thomas, Mayordomo, Jose I., Visus, Carmen, Appella, Ettore, Shabanowitz, Jeffrey, Hunt, Donald F., DeLeo, Albert B.
Publicado em 2009

Targeting ALDH(bright) human carcinoma initiating cells with ALDH1A1- specific CD8(+) T cells

Por Visus, Carmen, Wang, Yangyang, Lozano-Leon, Antonio, Ferris, Robert L., Silver, Susan, Szczepanski, Miroslaw J., Brand, Randall E., Ferrone, Cristina R., Whiteside, Theresa L., Ferrone, Soldano, DeLeo, Albert B., Wang, Xinhui
Publicado em 2011

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian can...

Por Rahma, Osama E., Ashtar, Ed, Czystowska, Malgorzata, Szajnik, Marta E., Wieckowski, Eva, Bernstein, Sarah, Herrin, Vincent E., Shams, Mortada A., Steinberg, Seth M., Merino, Maria, Gooding, William, Visus, Carmen, DeLeo, Albert B., Wolf, Judith K., Bell, Jeffrey G., Berzofsky, Jay A., Whiteside, Theresa L., Khleif, Samir N.
Publicado em 2011